This suggests that the main effect of clonazepam, and probably of benzodiazepines in general, may be an initial calming of the patient, which #GDC-0199 price randurls[1|1|,|CHEM1|]# also results in a reduction in scores in mania rating scales. A longer-lasting effect on core manic symptoms cannot be concluded from those studies, as they were only of short duration (maximum 14 days) and carried out in a small number Inhibitors,research,lifescience,medical of patients. Beneficial effects of clonazepam

in the short-term control of agitation in manic patients were also found in an open study of Bottai et al156 where the manic symptomatology was rated in a timeblind fashion and retrospectively correlated with plasma levels. The initial plasma levels that led to sufficient control of agitation were in the range of 18.9 to 34.0

lig/L. Chouinard Inhibitors,research,lifescience,medical et al157 also conducted a double-blind trial with clonazepam IM compared to haloperidol IM as initial treatment of agitated manic patients and reported equal efficacy with fewer, especially extrapyramidal, side effects. Only two controlled studies have been conducted on the prophylaxis of recurrence of BD, with disappointing results. Sachs et al158 compared clonazepam with haloperidol as an add-on to lithium prophylaxis. No significant difference was observed between the small groups (n=6 randomized to each treatment) after 12 weeks, however, 3 out of 6 patients on clonazepam Inhibitors,research,lifescience,medical still needed additional haloperidol. The other trial, by Aronson et al,159 was prematurely discontinued after the first 5 patients enrolled Inhibitors,research,lifescience,medical relapsed after 2 to 15 weeks. In summary, clonazepam may be an effective treatment, like other benzodiazepines, for rapid control of manic agitation; however, its medium- and long-term efficacy, especially against core manic symptoms, cannot be concluded from the trials so far. Phenytoin Inhibitors,research,lifescience,medical The efficacy of phenytoin in patients with affective disorders has not yet been investigated

systematically. Earlier anecdotal reports showed an effect on mood and hostility in populations with aggressive behavior88,89 and neurotically depressed patients.160 Not all of these results could be replicated in further case reports, so that these findings remain controversial. Linifanib (ABT-869) In contrast, one case report suggests that phenytoin induces organic mania.161 In a currently ongoing open trial, we are attempting to characterize potential benefits in manic patients receiving high oral loading doses of phenytoin (600-1000 mg/’d for 3 days, then tapering down according to plasma level). Preliminary results in the first 5 patients included suggest good tolerability and an initial beneficial effect on manic agitation; however, the effect appears transient and leaves other core manic symptoms unchanged. Barbiturate anticonvulsants Besides phenytoin, barbiturates are another group of anticonvulsants that has not received much attention in the treatment of BD.